HOLLISTON, Mass.--(BUSINESS WIRE)--Oligo Factory, a leading science-driven provider of high-quality custom DNA and RNA oligonucleotides for therapeutic, diagnostic, and life science applications, ...
Leverage 40 years of industry expertise at LGC Biosearch Technologies to produce high-quality research grade oligos tailored to your specific needs. Enjoy a wide range of probe chemistries, ...
The gold standard for DNA writing, phosphoramidite chemistry, works incredibly well on short, uncomplicated, oligos. For longer stretches of DNA, which may contain DNA with complex features such as ...
SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights the global oligonucleotide synthesis market is estimated to be valued at US$ 2,874.1 Million in 2020, and is expected to exhibit a CAGR ...
Oligo Factory, which manufactures oligonucleotides at scale, reports that it is compliant with current Good Manufacturing Practices (GMP). This milestone emphasizes Oligo Factory’s commitment to ...
In today’s competitive biotechnology landscape, control and speed define success for companies and core labs producing synthetic genes. Yet many gene synthesis teams still rely on outsourced oligo ...
With a broad selection of nucleic acid derivatives and customized oligo building blocks from LGC Biosearch Technologies, create unique research-grade oligos for any purpose, from unlabeled PCR primers ...
Oligos are playing a crucial role in driving the progress of modern drug development. Listen to nucleic acid synthesis expert Lina Borozdina deliver a complete class on oligo synthesis starting from ...
Synthetic Oligonucleotides are set for rapid expansion in healthcare, food production, and data storage. The technology, vital in both existing and new markets, promises vast growth potential often ...
During an oral Spotlight Presentation, Codexis unveiled the successful end-to-end enzymatic synthesis of an entire approved siRNA therapeutic asset, inclisiran. Codexis enzymatically synthesized the ...
Oligo Factory’s new low-scale synthesis capability gives researchers the flexibility to order single oligos or small prototype batches, at volumes as low as 50 nmol with the same speed, service, and ...